• HSBC

Novartis Consumer Health supports education of regional physicians

  • United Arab Emirates: Tuesday, November 13 - 2007 at 10:34
  • PRESS RELEASE

Through its VIP (Voltaren Emulgel Institute of Pain) program, Novartis Consumer Health recently provided 450 doctors from across the GCC with an internationally accredited Rheumatology and Pain continuous medical education (CME) course.

The VIP program supports professionals, who are required by governing health authorities to complete a minimum number of CME hours to maintain their medical license and practice in their respective countries. The course was provided and accredited by the American Academy of Continuing Medical Education (AACME), who has served as the international predominant standards-setting and accrediting body for continuing medical education for over 10 years in over 96 countries worldwide.

The course provided each physician with 27 hours of accreditation, in order to gain these hours, physicians had to complete the course in a specified time frame over a number of months.

"Novartis Consumer Health strives to provide the best medical education available to healthcare professionals as cost effectively as possible. The course which was sent to physicians on DvD is time friendly allowing them to choose the time and place to study,"


comments George Wagih, Marketing Manager, Novartis Consumer Health. "Through the Voltaren Emulgel Institute of Pain we have been able to ensure that physicians in the region have received the latest updates in medical thinking benefiting their patient's outcomes," he added.

According to Dr Basheer Ahamed, Consultant Orthopaedic, American Mission Hospital and successful participant of the VIP program, "Continuing medical education is now an essential component and a necessary requirement to practice. With our already busy schedules it can sometimes prove difficult, not to mention very expensive to do this. The VIP program was great as I received the DvDs on a monthly basis and it offered a comfortable way for me to conduct home studying."

Once each participant had successfully completed the DvD CME, the American AACME provided an accredited certificate confirming completion of the course. Following the success of the first phase of the program, the VIP programme is soon to be rolled out in Jordan, Lebanon and Palestine.
 
Article Options
Log in to request more information from Novartis

Notes and Media Contacts »

Media Inquiries:
Nadera Abuali
ASDA'A Public Relations,
Exclusive Affiliate of Edelman PR Worldwide in Middle East and North Africa
Manama, Bahrain
Tel: +973 17582033
Fax: +973 17582034
Mobile: +973 36301367

Voltaren Emulgel is a topical anti-inflammtory gel which acts on muscular pain and helps to speed up recovery. It can be used to treat general aches and pains, back neck and shoulder pain. It can also be used for traumatic swelling of tendons, ligaments, muscles and joints due to strains, bruises and sports injuries, as well as soft tissue rheumatism and localized rheumatic conditions. The fast acting Emulgel helps to relieve pain and reduce swelling. Its powerful non steroidal active ingredient, diclofenac, quickly penetrates deep to the site of pain, where it works to stop the pain, reduce swelling and combat inflammation mobility. The emulgel formula combines the cooling effect of a gel with a cream, which works to treat the root of the pain.

Disclaimer »

Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions